Human KALRN blocking peptide

Product Overview

Blocking/Immunizing peptide for anti-KALRN antibody

Target

KALRN

Nature

Synthetic

Tag/Conjugate

Unconjugated

Application Notes

For in vitro research use only. Not intended for any diagnostic or therapeutic purpose. Not for human or animal consumption.

Format

Lyophilized powder

Preservative

None

Storage

Shipped at ambient temperature, store at -20°C.

Entrez Gene ID

Antigen Description

Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Function

ATP binding; Rho guanyl-nucleotide exchange factor activity; guanyl-nucleotide exchange factor activity; metal ion binding; nucleotide binding; protein serine/threonine kinase activity;

Synonyms

KALRN; kalirin, RhoGEF kinase; HAPIP, huntingtin associated protein interacting protein (duo); kalirin; ARHGEF24; DUET; duo; Hs.8004; Kalirin; serine/threonine kinase with Dbl and pleckstrin homology domains; TRAD; huntingtin-associated protein interacting protein (duo); serine/threonine kinase with Dbl- and pleckstrin homology domains; serine/threonine-protein kinase with Dbl- and pleckstrin homology domain; DUO; CHD5; CHDS5; HAPIP; FLJ12332; FLJ16443; FLJ18196; FLJ18623;